Consider a long position in Ultragenyx Pharmaceutical (RARE) following its steep 47% sell-off, targeting a rebound toward $40–$50 per share based on its depressed valuation of roughly 2x sales. Position for upside in memory semiconductor producers like fundamentally strong Micron Technology (MU) and SanDisk, which are primed to benefit from potential U.S. tariffs on competitor SK Hynix. Consider short positions on Moderna (MRNA) as the company faces sustained downside pressure and an uncertain commercial pipeline. Watch for tactical short-selling setups in Robinhood Markets (HOOD) to capitalize on potential pullbacks following its rapid, crypto-fueled rally. Finally, stay invested in resilient enterprise software leaders like Snowflake (SNOW) as fears over AI disruption subside, while actively avoiding speculative quantum computing stocks that lack near-term commercial viability.

Ultragenyx Pharmaceutical Inc. (RARE)

• The stock crashed roughly 47% following clinical trial news regarding its Angelman syndrome program, which was viewed as expected by Shkreli.
• Shkreli is heavily bullish and took a large long position, calling it a high-conviction value opportunity.
  • The company is forecast to generate approximately $750 million in revenue and trades at roughly 2x sales, which is considered very cheap for a commercial-stage rare disease biologics company.
  • Shkreli noted CEO Emil Kakkis has a strong track record with the most rare disease FDA approvals in the industry.
• Price Target: Shkreli believes the stock can rebound to $40 to $50 per share, stating fair value is substantially higher than current depressed levels.

Takeaways

• Consider a long position at depressed valuations following clinical pipeline sell-offs, targeting a recovery toward $40–$50 driven by core commercial revenues and pipeline optionality.

SanDisk & Micron Technology (MU)

• Memory semiconductor producers are positioned to benefit from potential U.S. tariffs on Korean memory competitors like SK Hynix.
  • SanDisk serves as a direct pure-play on NAND flash memory, with attractive valuation and low short borrow fees (~6%).
  • Micron (MU) is considered fundamentally stronger than SanDisk, though SanDisk provides direct leverage to NAND price recovery.
• Keith actively traded SanDisk on the long side before taking profits.

Takeaways

• Memory chip makers (MU, SanDisk) offer upside if trade restrictions or tariffs hit international rivals, though investors should monitor broader semiconductor sector volatility.

Moderna, Inc. (MRNA)

• Shkreli expressed bearish sentiment toward Moderna, stating he views the stock as a candidate to short.
• He characterized the company's current position and pipeline outlook as a "very bizarre situation" with lingering downside pressure.

Takeaways

• Maintain caution or look for short opportunities on MRNA as post-pandemic commercial catalysts remain under scrutiny.

Robinhood Markets, Inc. (HOOD)

• The stock jumped roughly 10% following strong momentum and adoption in its crypto and blockchain infrastructure offerings.
• Despite acknowledging Robinhood's long-term dominance in modern retail finance and blockchain integration, Shkreli is eyeing potential short setups following aggressive rallies.

Takeaways

• While fundamentally supported by crypto adoption, HOOD presents potential pullback risk after rapid runs, creating short-term tactical short setups.

Intel Corporation (INTC) & Taiwan Semiconductor Manufacturing Co. (TSM)

• Trader Keith initiated short positions across major semiconductor names including INTC and TSM.
  • The TSM short position was subsequently stopped out for a loss amid ongoing chip market fluctuations.
  • Discussion highlighted how market reactions depend heavily on which specific chip lines face manufacturing or timeline delays (e.g., core flagship chips vs. lower-tier silicon).

Takeaways

• Approach semiconductor short positions with strict risk management and tight stop-losses, as technical momentum can easily overpower short theses.

Snowflake Inc. (SNOW)

• Snowflake surged over 22% following its earnings report.
• The move reflected a broader relief rally across software and enterprise cloud stocks, as market fears regarding rapid AI disruption displacing software platforms have proven overblown.

Takeaways

• Enterprise software remains resilient; strong quarterly earnings from category leaders like SNOW signal that AI fears were overly discounted into valuations.

Quantum Computing Sector

• Shkreli reiterated a heavily bearish macro stance on commercial quantum computing companies, labeling the technology vastly overhyped and speculative in its current state.
• He warned investors against chasing speculative quantum computing equities given the lack of commercially viable near-term applications.

Takeaways

• Avoid long-term speculative positions in pure-play quantum computing stocks until concrete enterprise adoption and proven technological viability materialize.

Godel Terminal / DL Software (Private Placement)

• The platform is conducting a $3 million seed extension round via a SAFE (Simple Agreement for Future Equity).
• The offering is targeting accredited investors at a valuation described as sub-$100 million at a low multiple of existing millions in recurring revenue.

Takeaways

• Accredited investors evaluating fintech data platforms may explore private allocations in Godel Terminal at conservative revenue multiples relative to broader software venture valuations.